Effect observation of combination therapy with nimodipine and oxiracetam of patients with type 2 diabetes mellitus combined with mild vascular cognitive impairment
10.3969/j.issn.1671-8348.2014.35.010
- VernacularTitle:尼莫地平联合奥拉西坦胶囊治疗T2DM患者合并轻度血管性认知障碍的疗效观察
- Author:
Xianjun TANG
- Publication Type:Journal Article
- Keywords:
diabetes mellitus,type 2;
vascular cognitive impairment;
C peptide;
nimodipine;
oxiracetam
- From:
Chongqing Medicine
2014;(35):4737-4739
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the efficacy of combination therapy with nimodipine and oxiracetam for type 2 diabetes melli‐tus(T2DM)patients with mild vascular cognitive impairment(mVCI) .`Methods Seventy‐two T2MD‐mVCI patients were divided into control group and observation group and each group was 36 cases .Control group was given routine treatment and nimodipine 40 mg ,3 times every day ;observation group was given oxiracetam 800 mg ,2 times every day ;the treatment course was 6 months .fast‐ing blood glucose(FBG) ,2 h postprandial hyperglycemia(2 h PBG) ,glycosylated hemoglobin A1C(HbA1C) ,C peptide level were recorded and MoCA cognitive function scale was used to evaluated patients cognitive function of each group before and after the treatment .Results Before the treatment ,both two groups with C peptide level were declined and mild cognitive impairment ,there were no statistically significant differences(P>0 .05) .After the treatment ,C peptide level ,MoCA scores and cognitive function sub‐scores of memory ,executive ,attention were significantly higher than before(P<0 .05);the observation group compared with the control group improved significantly(P< 0 .01) .Conclusion Combination therapy with nimodipine and oxiracetam could signifi‐cantly improve cognitive function in patients with T2DM‐mVCI ,its efficacy is superior to nimodipine .
